Here, we provide evidence that Art alleviates TIF by activating PPARγ-mediated inhibition of the TGF-β/Smad pathway, supporting Art as a promising therapeutic strategy for DKD and related fibrosis. The gene discussed is PPARG; the disease is diabetic kidney disease.